Unknown OBSERVATIONAL NCT04993274

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study (MOTOSENS)

Sensitivity of Quantitative Motor Performance Measures in Multiple Sclerosis - a Prospective Cohort Study Over Two Years Using Microsoft Kinect

Sponsor: Friedemann Paul

Conditions Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive

Interventions PASS-MS

Updated 4 times since 2021 Last updated: Aug 9, 2021 Started: Feb 20, 2019 Primary completion: Nov 30, 2022 Completion: Nov 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04993274, this observational or N/A phase trial focuses on Multiple Sclerosis, Chronic Progressive and Multiple Sclerosis, Relapsing-Remitting and remains ongoing. Sponsored by Friedemann Paul, it has been updated 4 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Sep 2023 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Sep 2021 — Sep 2023 [monthly]

Active Not Recruiting

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Friedemann Paul
Roche Pharma AG

Data source: Charite University, Berlin, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany